search
Back to results

A Feasibility Study of a Suicide Prevention Video

Primary Purpose

Suicidal Ideation, Suicide Attempts, Psychiatric Illness

Status
Completed
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Suicide prevention video
Standard suicide treatment
Sponsored by
Fraser Health
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Suicidal Ideation

Eligibility Criteria

19 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age 19 years or older
  • Admitted to the Royal Columbian Hospital under psychiatric services
  • Individuals will have had suicidal behaviours as part of their presentation leading to hospitalization
  • Individuals must be at the level 2 observation privileges or higher
  • Individuals must be capable of giving consent to participate in the study
  • Individuals must speak and read English fluently Individuals admitted to the hospital as voluntary and involuntary (certified) patients

Exclusion Criteria:

  • Individuals with hearing or visual deficits that impairs hearing or viewing the SPV
  • Individuals who are under the influence of drugs, such as intoxication or active withdrawal
  • Individuals with established diagnoses of cognitive impairment affecting their ability to give consent, understand what is expected of them in the study or follow directions
  • Patients that require a substitute decision makers to provide consent
  • Individuals whose behaviors an/or cognition are actively affected by ongoing psychosis, including hallucinations, delusions, and disorganized behaviors
  • Individuals whose treating team assess them as likely to have a negative response to the SPV, for example paranoia around electronic devices
  • Patient's who's attending physiatrist is one of the study team members
  • Patients who are currently under the direct care of any of the investigators Patients that had acute suicidality in the last 24 hours

Sites / Locations

  • Royal Columbian and Eagle Ridge Hospitals

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Suicide prevention video

Standard suicide treatment

Arm Description

In this group, in addition to receiving the standard of care for their suicidality, the participants will also view a suicide prevention video.

In this group, participants will only receive the standard of care for their suicidality, which can include medications and/or therapy. The care will be determine by their attending physician.

Outcomes

Primary Outcome Measures

An assessment of suicidal behaviours following the use of a video intervention
To assess the change in suicidality of patients admitted for such using the Modified Scale for Suicidal Ideation after being given an educational video explaining common misinformation about suicide.

Secondary Outcome Measures

Mean change from baseline in the expression of suicidal ideation on the Modified Scale for Suicidal Ideation at 48 hours, 3 months and 6 months
To measure the change in suicidal behaviours after viewing the video using the "The Modified Scale for Suicidal Ideation". The scale is used to assess the presence or absence of suicide ideation and the degree of severity of suicidal ideas. The benefit of this scale is that it was developed so that paraprofessionals could administer the scale, yet demonstrated excellent internal consistency and interrater reliability, correlated highly with clinician's ratings of suicidal ideation and risk, and discriminated between suicide attempters and nonattempters prior to hospitalization. The scale would be administered at baseline, after watching the video and at 3 and 6 months after watching the video. Each question is scored for a total score that is interpreted as degree of suicidal ideation. Total score range is 0 to 54. Higher scores indicate more severe suicidal ideations. Changes in the total scores will be analyzed.

Full Information

First Posted
August 23, 2016
Last Updated
November 3, 2021
Sponsor
Fraser Health
search

1. Study Identification

Unique Protocol Identification Number
NCT05119946
Brief Title
A Feasibility Study of a Suicide Prevention Video
Official Title
A Pilot Study of the Effectiveness of a Suicide Prevention Video Tool to Reduce the Incidence of Active Suicide Behavior in Individuals With Psychiatric Illness
Study Type
Interventional

2. Study Status

Record Verification Date
November 2021
Overall Recruitment Status
Completed
Study Start Date
January 2017 (Actual)
Primary Completion Date
June 2020 (Actual)
Study Completion Date
June 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Fraser Health

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
This initial study is a pilot feasibility study with a primary objective of assessing the feasibility of a larger study by evaluating the procedures and methodology, as well as collecting pilot data. The eventual research goal is to demonstrate whether a suicide prevention video in addition to standard care for suicidality is an effective strategy to reduce suicidal behaviours in individuals with a history of such. The suicide prevention video is developed as an educational tool to inform participants of the various consequences of suicide as well as giving a message of hope. It is hoped that such an approach will help to reduce future suicidal behaviours in those who have a history of such. If so, then this could be made as a part of the standard of care in treating patients with suicidality.
Detailed Description
This pilot study will assess the study procedures and methodology to determine the feasibility of a larger study that will be done to asses for any difference in suicidal behaviours when the suicide prevention video is used in addition to standard of care. As such, the primary objectives will include: Testing of recruitment, retention, consent, and assignment procedures Validating the inclusion/exclusion criteria Determining the acceptability and safety of the proposed intervention Evaluating implementation procedures and methodology for the intervention Evaluating the appropriateness of timing and frequency of data collection points Evaluating the appropriateness and feasibility of the assessment tools Obtaining parameters for sample size estimation for the larger study Assessing the effectiveness of the video medium, content in the video and length of the video

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Suicidal Ideation, Suicide Attempts, Psychiatric Illness

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
60 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Suicide prevention video
Arm Type
Experimental
Arm Description
In this group, in addition to receiving the standard of care for their suicidality, the participants will also view a suicide prevention video.
Arm Title
Standard suicide treatment
Arm Type
Active Comparator
Arm Description
In this group, participants will only receive the standard of care for their suicidality, which can include medications and/or therapy. The care will be determine by their attending physician.
Intervention Type
Behavioral
Intervention Name(s)
Suicide prevention video
Intervention Description
The video has been developed by the research team as an educational tool to teach patients about suicide, the consequences of such and imparting a message of hope.
Intervention Type
Other
Intervention Name(s)
Standard suicide treatment
Intervention Description
The standard suicide treatment will be determine by the attending physician and can include medications and/or psychotherapy
Primary Outcome Measure Information:
Title
An assessment of suicidal behaviours following the use of a video intervention
Description
To assess the change in suicidality of patients admitted for such using the Modified Scale for Suicidal Ideation after being given an educational video explaining common misinformation about suicide.
Time Frame
12 months
Secondary Outcome Measure Information:
Title
Mean change from baseline in the expression of suicidal ideation on the Modified Scale for Suicidal Ideation at 48 hours, 3 months and 6 months
Description
To measure the change in suicidal behaviours after viewing the video using the "The Modified Scale for Suicidal Ideation". The scale is used to assess the presence or absence of suicide ideation and the degree of severity of suicidal ideas. The benefit of this scale is that it was developed so that paraprofessionals could administer the scale, yet demonstrated excellent internal consistency and interrater reliability, correlated highly with clinician's ratings of suicidal ideation and risk, and discriminated between suicide attempters and nonattempters prior to hospitalization. The scale would be administered at baseline, after watching the video and at 3 and 6 months after watching the video. Each question is scored for a total score that is interpreted as degree of suicidal ideation. Total score range is 0 to 54. Higher scores indicate more severe suicidal ideations. Changes in the total scores will be analyzed.
Time Frame
12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
19 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age 19 years or older Admitted to the Royal Columbian Hospital under psychiatric services Individuals will have had suicidal behaviours as part of their presentation leading to hospitalization Individuals must be at the level 2 observation privileges or higher Individuals must be capable of giving consent to participate in the study Individuals must speak and read English fluently Individuals admitted to the hospital as voluntary and involuntary (certified) patients Exclusion Criteria: Individuals with hearing or visual deficits that impairs hearing or viewing the SPV Individuals who are under the influence of drugs, such as intoxication or active withdrawal Individuals with established diagnoses of cognitive impairment affecting their ability to give consent, understand what is expected of them in the study or follow directions Patients that require a substitute decision makers to provide consent Individuals whose behaviors an/or cognition are actively affected by ongoing psychosis, including hallucinations, delusions, and disorganized behaviors Individuals whose treating team assess them as likely to have a negative response to the SPV, for example paranoia around electronic devices Patient's who's attending physiatrist is one of the study team members Patients who are currently under the direct care of any of the investigators Patients that had acute suicidality in the last 24 hours
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Hem Phaterpekar, MD
Organizational Affiliation
Fraser Health
Official's Role
Principal Investigator
Facility Information:
Facility Name
Royal Columbian and Eagle Ridge Hospitals
City
New Westminster
State/Province
British Columbia
Country
Canada

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

A Feasibility Study of a Suicide Prevention Video

We'll reach out to this number within 24 hrs